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Abstract 
Background: High normal levels of thyroid‑stimulating hormone (TSH) have been reported to be associated with 
chronic kidney disease (CKD) among euthyroid individuals. However, there has been only limited research on the 
association between TSH and proteinuria, a major risk factor for the progression of renal disease.
Methods: A cross‑sectional study of 1595 euthyroid individuals was conducted. All participants were within the nor‑
mal range for free triiodothyronine (T3), free thyroxine (T4), and TSH. Analyses were stratified by thyroid cyst status to 
test the hypothesis that the absence of thyroid cysts, an indicator of latent thyroid damage, is associated with declin‑
ing ability to synthesis thyroid hormone.
Results: For participants with thyroid cysts, a significant inverse association between TSH and proteinuria was 
observed (adjusted odds ratio (95% confidence intervals) of log‑transformed TSH for proteinuria 0.40 (0.18, 0.89)). In 
participants without thyroid cysts, a significant positive association between those two factors was observed (2.06 
(1.09, 3.90)).
Conclusions: Among euthyroid individuals in the general population, being in the normal range of TSH was found to 
have an ambivalent association with proteinuria. Thyroid cyst status could be an effect modifier for those associations.
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Introduction
High normal levels of thyroid-stimulating hormone 
(TSH) have been reported to be associated with 
decreased glomerular filtration rate (GFR) [1] and 
chronic kidney disease (CKD) in euthyroid individuals 
[2].
Proteinuria is a major risk factor for the progres-
sion of renal disease [3]. Therefore, unlike GFR, which 
indicates current renal function, proteinuria is a useful 
marker for evaluating the progression of renal injury. 
However, few studies have evaluated the association 
between TSH and proteinuria among euthyroid indi-
viduals. A hospital-based Saudi Arabian study with 
euthyroid patients with diabetes reported a positive 
association between TSH levels and the severity of 
albuminuria and an inverse association between free 
thyroxine (T4) levels and the severity of albuminuria 
[4]. Therefore, in euthyroid individuals, high normal 
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TSH levels could be positively associated with pro-
teinuria, partly by indicating low normal ability to 
synthesis thyroid hormone. In contrast, high ability 
to synthesis thyroid hormone might have a beneficial 
influence by preventing proteinuria.
Anti-thyroid peroxidase antibody (TPO-Ab) is 
inversely associated with thyroid cysts in individuals 
with normal thyroid function [5]. Since thyroid per-
oxidase plays an important role in thyroid hormone 
synthesis [6], latent damage to the thyroid caused by 
TPO-Abs might reduce thyroid cysts. Therefore, the 
absence of thyroid cysts might negatively affect the 
activation and production of thyroid hormone.
In addition, demands for thyroid hormone might 
decrease with aging [7]. Since individuals with thy-
roid cysts are older than individuals without thyroid 
cysts [8, 9], individual with thyroid cysts might have 
enough capacity to synthesize thyroid hormone based 
on demand as indicated by TSH levels. Therefore, 
individuals with thyroid cysts might have relatively 
higher thyroid hormone activity, as we have previously 
reported [8, 9].
Furthermore, thyroglobulin plays a crucial role in the 
activation and synthesis of free triiodothyronine (T3) 
and free T4 [10]. The fluid in thyroid cysts is rich in 
thyroglobulin [11]. Thus, the presence or absence of 
thyroid cysts could influence the association between 
TSH and proteinuria in the general population. Indi-
viduals with thyroid cysts might benefit from extra 
thyroglobulin. Thus, thyroid cysts might have a benefi-
cial effect on thyroid hormone production.
Upon demand, TSH is secreted in the pituitary 
ground and activates the thyroid to increase periph-
eral free T3 and free T4 levels. Therefore, if the thy-
roid is functioning appropriately, TSH levels indicate 
the ability to synthesize thyroid hormone. However, if 
thyroid function declines, TSH levels indicate thyroid 
hormone deficiency, a risk factor for proteinuria.
Since individuals with thyroid cysts might benefit 
from the activation and production of thyroid hor-
mones [8, 9], we hypothesized that being in the normal 
range of TSH is inversely associated with proteinuria 
among euthyroid individuals with thyroid cysts in the 
general population. We also hypothesized that being in 
the normal range of TSH is positively associated with 
proteinuria among euthyroid individuals without thy-
roid cysts in the general population.
The aim of the present study was to clarify the 
associations between TSH and proteinuria stratified 
by thyroid cyst status by studying a Japanese general 




To clarify the influence of benign thyroid disease such as 
cysts and nodules on health, a thyroid survey was started 
in 2014. In 2014, 1883 individuals aged 40–74 years par-
ticipated in this survey. Based on this survey, we found 
that thyroid cysts could have clinical relevance, even 
though they were generally regarded as clinically insignif-
icant [5, 8, 9]. Since the present study is aimed to clarify 
one of the biological functions that thyroid cysts might 
possess, we used this thyroid survey, as in our previous 
studies [5, 8, 9].
In this cross-sectional study, the study population com-
prised 1883 Japanese individuals aged 40–74 years from 
the town of Saza in western Japan. These individuals 
underwent an annual medical check-up in 2014 as rec-
ommended by the Japanese government.
To avoid the influence of thyroid disease, individuals 
were excluded if they had a history of thyroid disease (n 
= 60); had missing data thyroid function such as TSH, 
free T3, and free T4 levels (n = 17); or who were out of 
the normal range for T3 (2.1–4.1 pg/mL), T4 (1.0–1.7 ng/
dL) (n = 77). Individuals out of the normal range for TSH 
(0.39–4.01 μIU/mL) were also excluded (n = 126).
Individuals without data on body mass index (BMI) (n 
= 1) or blood pressure (n = 1) were also excluded. Indi-
viduals were also excluded if data from serum tests (n = 
4) or drinking and smoking status (n = 2) were missing. 
The study included 1595 participants, with a mean age of 
60.5 years (standard deviation (SD), 9.1; range 40–74).
Data collection and laboratory measurements
Trained interviewers obtained information on clinical 
characteristics. Body weight and height were measured 
with an automatic body composition analyzer (BF-220; 
Tanita, Tokyo, Japan) to calculate BMI (kg/m2). Systolic 
blood pressure (SBP) and diastolic blood pressure (DBP) 
were recorded at rest.
A fasting blood sample was collected. TSH, free T3, 
and free T4 levels were measured using a chemilumines-
cent immunoassay (CLIA) at the LSI Medience Corpora-
tion (Tokyo, Japan). Normal ranges for free T3 (2.1–4.1 
pg/mL), free T4 (1.0–1.7 ng/dL), and TSH (0.39–4.01 
μIU/mL) based on this method were reported [12]. 
Hemoglobin  A1c (HbA1c), triglyceride (TG), high-den-
sity lipoprotein cholesterol (HDLc), and serum creatinine 
levels were measured using standard procedures at SRL, 
Inc. (Tokyo, Japan).
The presence of thyroid cysts was determined by expe-
rienced ultrasound technicians using a LOGIQ Book 
XP with a 10-MHz transducer (GE Healthcare, Milwau-
kee, WI, USA). For the present study, a thyroid cyst was 
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defined as a structure with a maximum diameter of ≥ 2.0 
mm and no solid components [5, 8, 9].
Spot urine dipstick was used to assess for the presence 
of proteinuria. Proteinuria was diagnosed as +1 or above.
Statistical analysis
In order to validate the study population in the present 
study, goodness of fit was evaluated using the Hosmer-
Lemeshow test.
To evaluate the secretory capacity of the pituitary 
gland, Jostel’s TSH index (TSHI) was calculated [13]. 
To evaluate the thyroid’s secretory capacity and global 
step-up deiodinase activity, maximum thyroid secretory 
capacity (SPINA-GT) and the overall activity of periph-
eral deiodinases (SPINA-GD) were also calculated using 
the diagnostic application of SPINA Thyr 4.1 (SciCrunch, 
University of California, CA, USA) [14, 15].
Characteristics of the study population were expressed 
as means ± SD, except for sex, daily drinker or current 
smoker status, and TSH. Sex and daily drinker or current 
smoker status were expressed as percentages. Since TSH 
values had a skewed distribution, log-transformed TSH 
values were used for analysis. TSH values were expressed 
as medians [the first quartile, third quartile]. We also 
evaluated sex- and age-adjusted values of thyroid hor-
mones (free T3 and free T4) associated with the status of 
thyroid cysts using analysis of covariance (ANCOVA).
Logistic regression was used to calculate odds ratios 
(ORs) and 95% confidence intervals (CIs) to determine 
the association between proteinuria and thyroid cysts 
and between proteinuria and TSH.
Two adjustment models were used. Model 1 adjusted 
for sex and age. Model 2 adjusted for variables in model 
1 and potential confounding factors directly associ-
ated with thyroid function: BMI (kg/m2), smoking sta-
tus (never, former, current), drinking status (none, often, 
daily), SBP (mmHg), HbA1c (%), TG (mg/dL), and HDLc 
(mg/dL). We also stratified analyses by thyroid cyst sta-
tus. For sensitivity analysis, we conducted sex-specific 
analyses using age-adjusted models. We also evaluated 
associations between log-transformed TSH values and 
proteinuria in participants without reduced renal func-
tion (defined as GFR ≥ 60 mL/min/1.73  m2). All statis-
tical analyses were performed with SAS for Windows 
(version 9.4: SAS Inc., Cary, NC, USA). P values < 0.05 
were regarded as statistically significant.
Results
Among 1595 study participants, 525 (32.9%) were diag-
nosed as having thyroid cysts and 86 (5.4%) were diag-
nosed with proteinuria.
Clinical characteristics of the study participants by thyroid 
cyst status
Table 1 shows the clinical characteristics of the study par-
ticipants by thyroid cyst status. Compared to participants 
without thyroid cysts, participants with thyroid cysts 
were significantly less likely to be male and current smok-
ers. They were significantly older and had significantly 
higher SBP and DBP.
To avoid the influence of sex and age, adjusted values 
for free T3 and free T4 values in participants with and 
without thyroid cysts were calculated. The least square 
mean (standard error) free T3 was 3.17 (0.01) pg/mL 
in participants with thyroid cysts and 3.17 (0.001) pg/
mL in participants without thyroid cysts (p = 0.980), 
whereas the least square mean (standard error) free T4 
was 1.25 (0.004) ng/dL and 1.25 (0.01) ng/dL (p = 0.530), 
respectively.
Associations between proteinuria and thyroid cyst status
Table  2 shows ORs and 95% CIs for proteinuria by 
thyroid cyst status. No significant associations were 
Table 1 Characteristics of study population
T3 triiodothyronine, T4 thyroxine, TSH thyroid-stimulating hormone, TSHI Jostel’s 
TSH index, SPINA-GT maximum thyroid secretory capacity, SPINA-GD overall 
activity of peripheral deiodinases, BMI body mass index, SBP systolic blood 
pressure, DBP diastolic blood pressure, HbA1c hemoglobin A1c, TG triglycerides, 
HDLc high-density lipoprotein cholesterol, GFR glomerular filtration rate. Values 
are mean ± standard deviation
*1: Values are median [the first quartile, third quartile]. Regression model for 
mean values was used for determining p values.
*2: Logarithmic transformation was used for evaluating p
Thyroid cyst p
(−) (+)
No. of participants 1070 525
Men, % 40.6 28.8 < 0.001
Postmenopausal women, % 44.7 59.8 < 0.001
Age, year 59.7 ± 9.4 62.0 ± 8.2 < 0.001
free T3, pg/mL 3.18 ± 0.32 3.15 ± 0.31 0.079
free T4, ng/dL 1.26 ± 0.16 1.24 ± 0.15 0.117
TSH, μIU/mL 1.52 [1.09, 2.14]*1 1.54 [1.07, 2.16]*1 0.689*2
TSHI 2.59 ± 0.52 2.57 ± 0.53 0.648
SPINA‑GT, pmol/s 3.7 ± 1.4 3.7 ± 1.3 0.497
SPINA‑GD, nmol/s 28.3 ± 3.8 28.3 ± 3.9 0.963
BMI, kg/m2 22.8 ± 3.3 22.6 ± 3.4 0.414
SBP, mmHg 124 ± 17 126 ± 17 0.003
DBP, mmHg 73 ± 11 74 ± 10 0.032
Current smoker, % 15.4 11.6 0.041
Daily drinker, % 41.2 39.6 0.542
HbA1c, % 5.6 ± 0.6 5.6 ± 0.5 0.055
TG, mg/dL 107 ± 81 101 ± 60 0.157
HDLc, mg/dL 60 ± 15 62 ± 15 0.110
GFR, mL/min/1.73  m2 71.8 ± 13.2 71.5 ± 12.7 0.633
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observed. Goodness of fit was validated for the present 
study population.
Association between proteinuria and TSH
Table 3 shows ORs and 95% CIs for proteinuria by TSH 
value. Overall, a slight, but not statistically significant, 
positive association between TSH level and proteinuria 
was observed. When we stratified by thyroid cyst sta-
tus, different associations were observed. A significant 
positive association was observed for participants with-
out thyroid cysts, whereas a significant inverse asso-
ciation was observed for participants with thyroid cysts. 
Goodness of fit was validated for the present study popu-
lation stratified by thyroid cyst status.
Investigations of associations between log-transformed 
TSH, thyroid cyst status, and proteinuria revealed a sig-
nificant interaction. The adjusted p values for this inter-
action were 0.001 in both the sex- and age-adjusted 
model and the fully adjusted model.
For sensitivity analysis, we conducted sex-specific anal-
ysis by using an age-adjusted model. We found essentially 
the same associations. The adjusted ORs and 95% CIs for 
proteinuria by log-transformed TSH in participants with 
and without thyroid cysts, respectively, were 0.73 (0.18, 
2.98) and 1.84 (0.74, 4.58) for men. The corresponding 
values for women were 0.31 (0.12, 0.83) and 2.36 (1.02, 
5.48).
Association between proteinuria and TSH 
among participants without reduced renal function
Results of additional analysis limited to participants 
without reduced renal function are shown in Table  4. 
We found essentially the same associations as among all 
participants. A significant positive association between 
proteinuria and log-transformed TSH was observed for 
participants without thyroid cysts, whereas a significant 
inverse association was observed for participants with 
thyroid cysts.
Investigations of the associations between log-trans-
formed TSH and thyroid cyst status and proteinuria 
Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) of 
proteinuria in relation to thyroid cyst
Ref reference. Model 1: adjusted for sex and age. Model 2: + BMI, smoking 
status (never, former, current), drinking status (none, often, daily), systolic blood 
pressure (SBP), triglycerides (TG), high-density lipoprotein cholesterol (HDLc), 
and hemoglobin A1c (HbA1c)
Thyroid cyst p p 
(goodness 
of fit test)(−) (+)
No. of participants 1070 525
No. of proteinuria cases 
(%)
56 (5.2) 30 (5.7)
Model 1 Ref 1.24 (0.78, 1.98) 0.367 0.475
Model 2 Ref 1.27 (0.76, 1.97) 0.400 0.975
Table 3 Odds ratios (ORs) and 95% confidence intervals (CIs) of proteinuria in relation to thyroid‑stimulating hormone (TSH) by 
thyroid cyst
Ref reference. Model 1: adjusted for sex and age. Model 2: + BMI, smoking status (never, former, current), drinking status (none, often, daily), systolic blood pressure 
(SBP), triglycerides (TG), high-density lipoprotein cholesterol (HDLc), and hemoglobin A1c (HbA1c). Tertile values of TSH for men and women are < 1.19 μIU/mL and < 
1.24 μIU/mL for (low), 1.19-1.82 μIU/mL and 1.24-1.96 μIU/mL for (medium), and 1.83 μIU/mL ≤ and 1.97 μIU/mL ≤ for (high)
TSH levels p Log TSH p 
(goodness 
of fit test)(Low) (Medium) (High)
Total
 No. of participants 526 539 530
 No. of proteinuria cases (%) 25 (4.8) 30 (5.6) 31 (5.8)
 Model 1 Ref 1.21 (0.70, 2.08) 1.32 (0.76, 2.27) 0.325 1.13 (0.70, 1.81) 0.933
 Model 2 Ref 1.19 (0.68, 2.07) 1.35 (0.77, 2.36) 0.296 1.14 (0.70, 1.86) 0.370
Thyroid cyst (−)
 No. of participants 344 374 352
 No. of proteinuria cases (%) 9 (2.6) 22 (5.9) 25 (7.1)
 Model 1 Ref 2.39 (1.08, 5.26) 3.06 (1.40, 6.69) 0.005 2.10 (1.13, 3.90) 0.135
 Model 2 Ref 2.38 (1.07, 5.30) 3.08 (1.38, 6.86) 0.006 2.06 (1.09, 3.90) 0.647
Thyroid cyst (+)
 No. of participants 182 165 178
 No. of proteinuria cases (%) 16 (8.8) 8 (4.8) 6 (3.4)
 Model 1 Ref 0.55 (0.23, 1.34) 0.37 (0.14, 0.98) 0.037 0.41 (0.18, 0.89) 0.842
 Model 2 Ref 0.54 (0.21, 1.38) 0.34 (0.12, 0.94) 0.031 0.40 (0.18, 0.89) 0.849
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revealed a significant interaction. The adjusted  p val-
ues for this interaction were 0.001 in the sex- and age-
adjusted model and < 0.001 in the fully adjusted model. 
Goodness of fit was validated for the present study pop-
ulation stratified by thyroid cyst status (p ≥ 0.05) (not 
shown in table).
Discussion
The major finding of the present study with euthyroid 
participants from a general population was that there is 
a significant inverse association between TSH and pro-
teinuria in individuals with thyroid cysts and a significant 
positive association between those two factors in individ-
uals without thyroid cysts. Thus, thyroid cyst status could 
affect the association between TSH and proteinuria.
Among euthyroid individuals, high normal levels of 
TSH have been reported to be associated with decreased 
renal function [1, 2]. A previous case-control study with 
159 participants with renal disease and proteinuria and 
900 control participants showed that participants with 
proteinuria have higher TSH values than controls [16]. 
On the other hand, a large cross-sectional study with 
74,356 participants aged ≥ 20 years found that subclini-
cal hypothyroidism is a novel risk factor for reduced renal 
function but not proteinuria [17]. These findings are 
compatible with our present results, which show a small 
positive association between TSH and proteinuria among 
participants overall, but it was not statistically significant.
Thyroid hormones play a protective role in the kidney 
through the inhibition of nuclear factor-κB pathways, 
possibly by affecting the pro-inflammation and anti-
inflammation balance that affects the development of 
CKD [18]. Another study reported that thyroid hormone 
plays a direct role in endothelial repair [19, 20]. Since 
endothelial dysfunction is a well-known cause of CKD 
[21], higher thyroid hormone activity could have a ben-
eficial effect in preventing CKD.
Proteinuria is a major risk factor of renal disease pro-
gression [3]. Proteinuria of increasing severity is asso-
ciated with a faster rate of renal decline [22]. Thus, the 
severity of proteinuria could be useful for evaluating the 
protective effect of thyroid hormones against kidney 
injury.
TSH, by definition, stimulates the secretion of thyroid 
hormones. In the present study, for participants with thy-
roid cysts, TSH was found to be significantly inversely 
associated with proteinuria. For participants without thy-
roid cysts, TSH was found to be significantly positively 
associated with proteinuria. Because similar TSHI values 
were observed between euthyroid participants with and 
without thyroid cysts, pituitary function is not the best 
explanation for these paradoxical results.
Previously, TPO-Ab titers were revealed to be inversely 
associated with thyroid cysts among 1432 Japanese indi-
viduals with normal thyroid function (defined by being in 
the normal range for free T3 and free T4). When adjusted 
for known cardiovascular risk factors, the OR and 95% CI 
for thyroid cyst with respect to log-transformed TPO-
Ab titer was 0.67 (0.58, 0.78) [5]. Since TPO-Ab causes 
autoimmune thyroid disease [23], latent damage of the 
thyroid might be associated with the absence of thyroid 
cysts. In addition, being in the normal range for TPO-Ab 
titer was positively associated with atherosclerosis among 
1087 euthyroid Japanese individuals; the adjusted OR 
and 95% CI for atherosclerosis with respect to log-trans-
formed TPO-Ab titer was 2.65 (1.27, 5.51) [24]. Since 
endothelial dysfunction is recognized as a mechanism 
that leads to glomerular injury and atherosclerosis [25], 
atherosclerosis is positively associated with CKD [26]. 
Therefore, latent damage of the thyroid might influence 
the progression of renal disease.
However, in the present study, similar SPINA-GT and 
SPINA-GD were observed in individuals with versus 
without thyroid cysts. All participants in this study were 
within the normal range for free T3, free T4, and TSH. 
Therefore, different levels of thyroid hormone demand 
between euthyroid individuals with and without thyroid 
cysts might be the basis for those associations.
Energy that is necessary for living is mainly produced 
in the mitochondria. Growth differentiation factor-15 
Table 4 Odds ratios (ORs) and 95% confidence intervals (CIs) of proteinuria in relation to thyroid‑stimulating hormone (TSH) by 
thyroid cyst among subjects without reduced renal function
Ref reference. Model 1: adjusted for sex and age. Model 2: + body mass index (BMI), smoking status (never, former, current), drinking status (none, often, daily), systolic 
blood pressure (SBP), triglycerides (TG), high-density lipoprotein (HDLc), and hemoglobin A1c (HbA1c)
Total Thyroid cyst (−) Thyroid cyst (+)
Log TSH p Log TSH p Log TSH p
No. of participants 1327 898 429
No. of proteinuria cases (%) 66 (5.0) 41 (4.6) 25 (5.8)
Model 1 1.12 (0.65, 1.92) 0.688 2.38 (1.15, 4.91) 0.020 0.35 (0.14, 0.86) 0.022
Model 2 1.13(0.64, 1.98) 0.678 2.35 (1.11, 5.00) 0.026 0.33 (0.13, 0.85) 0.021
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(GDF-15), a potential biomarker of mitochondrial dys-
function, is elevated in aging and age-related disorders 
[27, 28]. However, even when thyroid hormone activates 
energy production, serum GDF-15 levels were elevated 
in patients with hyperthyroidism [29]. Therefore, age-
related declines in energy production might stimulate 
production of thyroid hormone.
On the other hand, since decreased thyroid func-
tion may lead to extended longevity [7], aging processes 
decrease the demand on thyroid hormone activity. Age-
related declines in physical activity reduce the demands 
for thyroid hormone. In addition, age-related declines in 
the demand for thyroid hormone might reduce the pro-
duction of thyroid hormone.
Therefore, to maintain energy homeostasis and to adapt 
to age-related physical changes, the thyroid might make 
fine adjustments within the normal range of thyroid hor-
mone and TSH levels. Thus, thyroid hormone demand, 
rather than serum levels of thyroid hormone and TSH, 
could be an important determinant for this adjustment.
Individuals with thyroid cysts are typically older than 
those without thyroid cysts [8, 9, 30, 31]. Therefore, 
thyroid cysts could be formed during the aging pro-
cess, which is related to decreasing demand for thyroid 
hormone [30, 31]. Since thyroid cyst fluid is rich in thy-
roglobulin [11], thyroid cysts might act as storage of thy-
roglobulin. Thus, thyroid cysts might have a beneficial 
influence on thyroid hormone secretion when necessary 
[8, 9, 30, 31].
Furthermore, in our previous study of 1020 partici-
pants in the normal range for free T3 and free T4 and not 
taking anti-hypertensive medications, the presence of a 
thyroid cyst was positively associated with isolated sys-
tolic hypertension but not with isolated diastolic hyper-
tension; the fully adjusted OR and 95% CI was 1.78 (1.12, 
2.85) for isolated systolic hypertension and 0.81 (0.21, 
3.16) for isolated diastolic hypertension [9]. Since hyper-
thyroidism is a major secondary cause of isolated systolic 
hypertension [32], euthyroid participants with thyroid 
cysts might have relatively higher thyroid hormone activ-
ity than those without thyroid cysts. This association also 
might indicate that age-related declines in the demand 
for thyroid hormone, which is related to the presence of 
thyroid cysts, could have a beneficial influence on thyroid 
hormone activity.
In addition, our previous study with 1724 euthyroid 
participants (i.e., individuals within the normal range of 
free T3 and free T4) also revealed that for those with-
out thyroid cysts, TSH is significantly positively asso-
ciated with hypertension [fully adjusted OR, 1.27; 95% 
CI (1.01, 1.61)] but this association was not observed 
for individuals with thyroid cysts [0.79 (0.57, 1.09)] [8]. 
Since euthyroid participants with thyroid cysts might 
have comparatively higher ability to synthesize thy-
roid hormone than those without thyroid cysts [8, 9] 
and hypothyroidism is a recognized cause of second-
ary hypertension [33], the study findings partly support 
our hypothesis that TSH levels might indicate thyroid 
hormone deficiency among individuals without thyroid 
cysts.
Since thyroid cysts might have a beneficial influence 
on activating thyroid hormone synthesis [8, 9] among 
individuals with thyroid cysts, TSH levels might indi-
cate thyroid hormone activity that has a protective effect 
against renal injury. Among individuals without thyroid 
cysts, TSH levels indicate thyroid hormone deficiency. 
Among individuals with thyroid cysts, an inverse asso-
ciation between TSH and proteinuria was observed. In 
contrast, among individuals without thyroid cysts, a 
positive association between TSH and proteinuria was 
observed.
Since higher thyroid hormone activity could prevent 
the progression of CKD [18-21], thyroid cysts could 
be inversely associated with proteinuria and reflect the 
absence of latent thyroid damage. However, in the pre-
sent study, no significant associations between thyroid 
cyst status and proteinuria were observed.
Aging is a well-known risk factor for cardiovascular 
disease and reduced renal function. Polycystic thyroid 
disease (PCTD) is a rare condition that is reported to 
be associated with subclinical or overt hypothyroidism. 
PCTD is more common in older individuals [34]. Since 
aging also might reduce the necessity of thyroid hormone 
activity [7] and might be associated with thyroid cyst 
development [8, 9, 30, 31], biological aging might be an 
important consideration while evaluating the influence of 
thyroid hormone and thyroid cysts on proteinuria.
Levels of GDF-15, which is considered a marker of 
biological age [27], were elevated in individuals with 
hyperthyroidism [29]. Since higher GDF-15 levels are 
associated with renal outcomes [35], biological age could 
be an important determinant of the association between 
TSH and proteinuria. Further investigation with data on 
GDF-15 is necessary to clarify those associations.
From a clinical perspective, the present study indi-
cates that thyroid cysts could play an important ben-
eficial role in thyroid hormone synthesis among 
participants with reduced demand of thyroid hormone. 
We evaluated thyroid function in a euthyroid popula-
tion, i.e., individuals within the normal ranges for TSH, 
free T3, and free T4. We concluded that those three fac-
tors are not sufficient for evaluating thyroid function. 
Furthermore, in evaluating mortality, proteinuria has 
been reported to be more useful than GFR, especially 
in participants with higher GFR levels [36–38]. When 
we limited our analysis to subjects without reduced 
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renal function, we found that TSH has a positive asso-
ciation with proteinuria in participants without thyroid 
cysts and an inverse association in participants with 
thyroid cysts. These results could be useful in clarifying 
the mechanism underlying age-related changes in thy-
roid function and provide a novel strategy for reducing 
the risk of mortality associated with proteinuria.
This study has potential limitations that warrant con-
sideration. First, we thought that thyroid cysts might 
influence the activity of thyroid hormones but not 
their plasma concentrations. However, we were unable 
to evaluate thyroid hormone activity with precision in 
this study. Since nitric oxide could act as an indicator of 
thyroid replacement therapy [39], further investigation 
with a marker of oxidative stress such as nitric oxide is 
necessary. Second, although fluid from thyroid cysts is 
rich in thyroglobulin, the presence of anti-thyroglobulin 
antibodies decreases thyroglobulin levels dramatically 
[11]. Thus, anti-thyroglobulin antibodies might act as 
a strong confounding factor in our analysis. However, 
because of the limited volume of blood samples, we 
could not evaluate the influence of anti-thyroglobulin 
antibodies. The presence of anti-thyroglobulin antibod-
ies might have a strong confounding effect, weakening 
the association between TSH and proteinuria. However, 
in the present study, significant associations in oppos-
ing directions were found between TSH and proteinuria 
according to thyroid cyst status. We evaluated the pres-
ence or absence of thyroid cysts. However, the number 
of cysts and the size of a given cyst could be important 
factors that affect the influence of thyroid cysts on thy-
roid hormone activity since PCTD is reported to be 
associated with hypothyroidism [34]. Further investi-
gation is necessary. In this study, proteinuria was diag-
nosed using a urine dipstick test. To evaluate the precise 
risk for renal disease progression, quantitative tests for 
markers such as urinary albumin level are necessary. 
Finally, because this was a cross-sectional study, no 
causal relationship could be established. Further investi-
gation with a longitudinal study is necessary.
Conclusions
In conclusion, among euthyroid individuals, being in the 
normal range of TSH is inversely associated with proteinu-
ria among individuals with thyroid cysts, but positively 
associated with proteinuria in individuals without thyroid 
cysts. The presence of thyroid cysts could be an effect 
modifier for the association between TSH and proteinuria.
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